FDA applicant
Nipro Medical Corporation
FDA records 62 decisions for Nipro Medical Corporation (Miami, FL) from 1997 to 2026: 62 510(k) clearances. Most are in product codes FMF (Syringe, Piston) and KDI (Dialyzer, High Permeability With Or Without…). Since 2016 its 510(k)s took a median of 246 days from receipt to decision, against 119 for FDA’s reviews in the same codes and years. Its devices cite 68 predicates, 21 of them its own earlier devices. 14 recalls are linked to its devices.
FDA’s records also spell it “Nipro Medical Corp.”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Nipro Medical Corporation’s devices, and how often a recall has named them.
FDA decisions per year
1in 2023
2026 so far, outlined.
Recalls per year
1in 2025
Class I Class II/III not classified
Planning a device like Nipro Medical Corporation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Nipro”
FDA records each applicant name separately; these may or may not be the same firm.